(Q46911439)

26 December 2017

title

The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly (English)

1 reference

26 December 2017

1 reference

8

Giulio Maira

1 reference

26 December 2017

Laura De Marinis

1

object named as

Laura De Marinis

1 reference

26 December 2017

author name string

Antonio Bianchi

2

1 reference

26 December 2017

Gherardo Mazziotti

3

1 reference

26 December 2017

Marco Mettimano

4

1 reference

26 December 2017

Domenico Milardi

5

1 reference

26 December 2017

Alessandra Fusco

6

1 reference

26 December 2017

Vincenzo Cimino

7

1 reference

26 December 2017

Alfredo Pontecorvi

9

1 reference

26 December 2017

Andrea Giustina

10

1 reference

26 December 2017

publication date

1 January 2008

1 reference

26 December 2017

published in

Pituitary

1 reference

26 December 2017

volume

11

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

13-20

1 reference

26 December 2017

Diagnosis and treatment of acromegaly complications

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11102-007-0062-6

Acromegalic cardiomyopathy: evaluation of the left ventricular diastolic function in the subclinical stage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-007-0062-6

Cardiovascular effects of the somatostatin analog octreotide in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-007-0062-6

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-007-0062-6

H9c2 cardiac muscle cells express all somatostatin receptor subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-007-0062-6

The effects of octreotide in dilated cardiomyopathy: an open-label trial in 12 patients

21 January 2018

1 reference

12 December 2020

Consensus statement: medical management of acromegaly

1 reference

12 December 2020

Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

1 reference

12 December 2020

Rapid reduction of left ventricular hypertrophy in acromegaly after suppression of growth hormone hypersecretion

1 reference

12 December 2020

1 reference

12 December 2020

Somatostatin in the human heart and comparison with guinea pig and rat heart

1 reference

12 December 2020

Positive inotropic effect of somatostatin in guinea-pig ventricular muscles

1 reference

12 December 2020

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

12 December 2020

Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly

1 reference

12 December 2020

Effect of a new somatostatin analogue SMS 201-995 (Sandostatin) on the renin-aldosterone axis

1 reference

12 December 2020

Long-term outcome of patients with acromegaly and congestive heart failure

1 reference

12 December 2020

Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study.

1 reference

12 December 2020

Central effects of somatostatin: pressor response, AVP release, and sympathoinhibition

1 reference

12 December 2020

Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide

1 reference

12 December 2020

Premature mortality due to cardiovascular disease in hypopituitarism

1 reference

12 December 2020

Echocardiographic assessment of cardiac anatomy and function in acromegalic patients

1 reference

12 December 2020

Acromegalic cardiomyopathy. Left ventricular filling and hypertrophy in active and surgically treated disease

1 reference

12 December 2020

Long-acting somatostatin analog therapy of acromegaly: a meta-analysis

1 reference

12 December 2020

A hyperkinetic heart in uncomplicated active acromegaly. Explanation of hypertension in acromegalic patients?

1 reference

12 December 2020

Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements

1 reference

12 December 2020

Prognostic significance of left ventricular mass change during treatment of hypertension

1 reference

12 December 2020

Heart failure responding to octreotide in patient with acromegaly

1 reference

12 December 2020

Cell death in acromegalic cardiomyopathy

1 reference

12 December 2020

Antiproliferative effects and insulin-like growth factor-I expression in Balb-C 3T3 fibroblasts after treatment with somatostatin and gonadotropin-releasing hormone analogs

1 reference

12 December 2020

Insulin-like growth factor I and its binding proteins in the cardiovascular system

1 reference

12 December 2020

Cardiovascular consequences of early-onset growth hormone excess

1 reference

12 December 2020

Management of pituitary tumors

1 reference

12 December 2020

Growth hormone regulates the level of insulin-like growth factor-I mRNA in rat skeletal muscle

1 reference

12 December 2020

Criteria for cure of acromegaly: a consensus statement

1 reference

12 December 2020

Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients

1 reference

12 December 2020

Signaling pathways for cardiac hypertrophy and failure

1 reference

12 December 2020

Systemic complications of acromegaly: epidemiology, pathogenesis, and management

1 reference

12 December 2020

Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients

1 reference

12 December 2020

Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation

1 reference

12 December 2020

Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly.

1 reference

12 December 2020

Growth hormone and the heart

1 reference

12 December 2020

Impact of patient's age and disease duration on cardiac performance in acromegaly: a radionuclide angiography study

1 reference

12 December 2020

Regression of acromegalic left ventricular hypertrophy after lanreotide (a slow-release somatostatin analog)

1 reference

12 December 2020

Cardiovascular effects of short-term growth hormone hypersecretion.

1 reference

12 December 2020

Cardiovascular effects of a single slow release lanreotide injection in patients with acromegaly and left ventricular hypertrophy

1 reference

12 December 2020

Demonstration of direct effects of growth hormone on neonatal cardiomyocytes

1 reference

12 December 2020

Improvement of cardiac function after treatment with octreotide followed by trans-sphenoidal surgery in an acromegalic patient who presented with congestive heart failure

1 reference

12 December 2020

Growth hormone and the heart

1 reference

12 December 2020

Different pharmacological responses of atrium and ventricle: studies with human cardiac tissue

1 reference

12 December 2020

10.1007/S11102-007-0062-6

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017